Puromicina diclorhidrato

Proveedor: MP Biomedicals

ICNA0210055210EA 42.5 EUR
ICNA0210055210 ICNA0210055283 ICNA0210055280 ICNA0210055291 ICNA0210055290 ICNA0210055225
Puromicina diclorhidrato
Puromycin dihydrochloride

Puromycin is nucleoside antibiotic & protein synthesis inhibitor that causes premature chain termination by acting as an analogue of the 3′-terminal end of aminoacyl-tRNA. Prevents growth of bacteria, protozoa, algae, and mammalian cells.


Puromycin is an antibiotic of unique structure and biological activity. It is produced by fermentation using Streptomyces albo-niger. There are four aspects of puromycin's biological activity that are 1) anti tumour effect; 2) nephrotoxic action; 3) inhibition of purine and/or protein synthesis and 4) antitrypanosome activity.


Soluble in water (50 mg/ml - clear, colorless solution).

Formula: C₂₂H₂₉N₇O₅·2HCl
MW: 544,44 g/mol
Número MDL: MFCD00012691
Núm. CAS: 58-58-2

Order Now

Resultados test especificaciones

Synonyms 6-dimethylamino-9-(3'-deoxy-3'-(p-methoxy-L-phenylalanyamino)- B-D-ribofuranosyl)-purine
Form Off-white Powder
Storage Store at -0 °C
Extinction Coefficient 20,3 (275 nm; 0,1 N NaOH); 19,5 (268 nm, 0,1 NHCl) (Lit.)
pka 6,8; 7,2 (Lit.)
Source Streptomyces albo-niger

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Más About VWR